Logo 1 Logo 2

Clinical Trial Details

Trial ID: L3546
Source ID: NCT00423501
Associated Drug: Placebo
Title: A Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.
Acronym:
Status: COMPLETED
Study Results: NO
Results:
Conditions: Diabetes Mellitus Type 2
Interventions: DRUG: Placebo|DRUG: taspoglutide|DRUG: taspoglutide|DRUG: taspoglutide|DRUG: taspoglutide|DRUG: taspoglutide
Outcome Measures: Primary: Absolute change from baseline in HbAlc, Week 8 | Secondary: Absolute change from baseline in FPG, fructosamine, body weight, fasting insulin, C-peptide, glucagon., Week 8|Changes in lipid profile, Week 8|AEs, laboratory parameters, primary pharmacokinetic parameters, Throughout study
Sponsor/Collaborators: Sponsor: Hoffmann-La Roche
Gender: ALL
Age: ADULT, OLDER_ADULT
Phases: PHASE2
Enrollment: 306
Study Type: INTERVENTIONAL
Study Designs: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Start Date: 2007-02
Completion Date: 2007-11
Results First Posted:
Last Update Posted: 2016-11-02
Locations: Washington, District of Columbia, 20010, United States|Woodstock, Georgia, 30189, United States|Chicago, Illinois, 60607, United States|Springfield, Illinois, 62704-1433, United States|Rochester, New York, 14609, United States|Portland, Oregon, 97239, United States|Dallas, Texas, 75246, United States|Midland, Texas, 79707, United States|San Antonio, Texas, 78229, United States|Richmond, Virginia, 23249, United States|Adelaide, 5000, Australia|Camperdown, 2050, Australia|Dimitrovgrad, 6400, Bulgaria|Pleven, 5800, Bulgaria|Ruse, 7002, Bulgaria|Sofia, 1233, Bulgaria|Sofia, 1606, Bulgaria|Varna, 9010, Bulgaria|Bad Lauterberg, 37431, Germany|Berlin, 10115, Germany|Görlitz, 02826, Germany|Hannover, 30167, Germany|Mainz, 55116, Germany|Neuss, 41460, Germany|Nürnberg, 90402, Germany|Guatemala City, 01015, Guatemala|Hong Kong, Hong Kong|Riga, 1002, Latvia|Kaunas, 51270, Lithuania|Klaipeda, 92304, Lithuania|Vilnius, 08661, Lithuania|Guadalajara, 44340, Mexico|Guadalajara, 44650, Mexico|Mexico City, 03100, Mexico|Mexico City, 11650, Mexico|Mexico City, 14080, Mexico|Mexico City, 14610, Mexico|Monterrey, 64460, Mexico|Pachuca, 42086, Mexico|Brasov, 500365, Romania|Bucharest, 020475, Romania|Bucharest, 050452, Romania|Bucharest, Romania|Cluj-napoca, 400006, Romania|Jud Covasna, 520064, Romania|Mures, 540011, Romania|Ploiesti, 100163, Romania|Satu Mare, 3900, Romania|Sibiu, 550245, Romania
URL: https://clinicaltrials.gov/show/NCT00423501

Drug ID Drug Name Type DrugBank ID Targets Category Latest Progress